Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Anna Glaser
Dynamiques des organisations
Les décrypter pour un monde plus durable et équitable Existe au format livre et ebook Les organisations façonnent notre monde… pour le meilleur et pour le pire. Mais comment pouvons-nous concevoir des organisations qui répondent aux défis sociétaux pour un monde plus durable ? En décryptant leur monde complexe. ... Présentation du livre Les organisations façonnent notre monde… pour le meilleur et pour le pire.
Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
Key Points Question Is premorbid sociodemographic status associated with multiple sclerosis severity, independent of treatment? Findings In this nationwide cohort study of 4557 patients in a universal health care context, higher premorbid educational attainment and income were associated with up to 47% milder subsequent disability and patient-reported symptoms in both relapse-onset and progressive-onset disease, after adjusting for individual treatment.
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
Abstract Background: Multiple sclerosis (MS) quality of care guidelines are consensus-based. The effectiveness of the recommendations is unknown. Objective: To determine whether clinic-level quality of care affects clinical and patient-reported outcomes. Methods: This nationwide observational cohort study included patients with adult-onset MS in the Swedish MS registry with disease onset 2005–2015.
Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry - Tim Spelman, Lars Forsberg, Kyla McKay, Anna Glaser, Jan Hillert, 2021
1. Barr, TA, Shen, P, Brown, S, et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells. J Experiment Med 2012; 209(5): 1001–1010. Google Scholar | Crossref | Medline | ISI 2. Bar-Or, A, Fawaz, L, Fan, B, et al. Abnormal B-cell cytokine responses a trigger of T-cell–mediated disease in MS? Ann Neurol 2010; 67(4): 452–461. Google Scholar | Crossref | Medline 3. Luna, G, Alping, P, Burman, J, et al.
A comparative study of teriflunomide and dimethyl fumarate within the Swedish MS Registry
Introduction Multiple sclerosis is a chronic inflammatory condition of the central nervous system affecting more than 2 million people worldwide.1 The most common phenotype of MS is the relapsing form (RMS), for which there are approximately 20 currently approved treatments. Within first-line therapy, the oral medications teriflunomide and dimethyl fumarate (DMF), introduced in 2013–2014, have largely replaced platform injectable therapies.
Enabling nanotechnology entrepreneurship in a French context: Towards a holistic theoretical framework
The purpose of this paper is to build a holistic theoretical framework of enabling factors contributing to the development of enterprise in nanotechnology-related industries, in a French context. A systematic literature review methodology was adopted.
Enabling nanotechnology entrepreneurship in a French context
The purpose of this paper is to build a holistic theoretical framework of enabling factors contributing to the development of enterprise in nanotechnology-related industries, in a French context. A systematic literature review methodology was adopted.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Anna
Contact Anna, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack